|
Published by: Mintel International Group Ltd.
Published: Jul. 1, 2003 - 66 Pages
Table of Contents
Introduction
Definition
Abbreviations
Executive Summary
Incidence of minor ailments
Smallest of the five markets
Again, pharmacies are the key distribution outlet
Who to target
Market Drivers
Incidence of ailments
Figure 1: Ailments suffered in the last 12 months, by all adults and complementary medicine group, 2002
Figure 2: Complaints suffered from in the last 12 months (colds/flu and related conditions and headaches), by demographic sub-group, 2002
Headaches the most common ailment
Figure 3: Complaints suffered from in the last 12 months (digestive, hayfever and joint pain), by demographic sub-group, 2002
An ageing population
Figure 4: Trends in the Spanish population, by age groups, 1995-2001
PDI trends
Figure 5: Trends in personal disposable income and consumer expenditure, at 1995 prices,
1995-2001
The Market
Legal status and legislation
Market size
Figure 6: Per capita spend on complementary medicines and self-medication, by country, 2002
Distribution
Figure 7: Trends in the number of community pharmacies, 1990-2001
The Supply Structure
Companies and brands
Aquilea
Dolisos
Espsilon
Floressance
El Granero
Pinisan
Plameca
Santiveri
Solgar
Tegor Laboratories
Ynsadiet
New Product Development
2002
2001
The Consumer
Attitudes towards health and the use of complementary medicines
Figure 8: Attitudes towards health, by all adults and complementary medicines group, 2002
Figure 9: Attitudes towards health and lifestyle, by country, 2002
Figure 10: Attitudes towards health, by demographic sub-group, 2002
Women and older consumers have greatest interest in their health
Affluent consumers and those in the North are prime targets
Figure 11: Faith in homeopathic medicine/prefer to treat illness with herbs, by complementary medicines group, by country, 2002
Figure 12: Prefer to treat illness with herbs, CMG vs. all adults, by country, 2002
Profile of the complementary consumer
Figure 13: Profile of complementary medicines group, by age and income, by country, 2002
Asking for advice
Figure 14: Whom consulted in the last 12 months, by all adults and complementary medicine group, 2002
Figure 15: Whom consulted in the last 12 months, by all adults, by country, 2002
Figure 16: Whom consulted in the last 12 months, by demographc sub-group, 2002
Usage of medicines
Figure 17: Products taken/used in the last 12 months, by all adults and complementary medicine group, 2002
Complementary medicine group has higher use of remedies
Figure 18: Products taken/used in the last 12 months, by demographic sub-group, 2002
Figure 19: Products used by complementary medicine group, by demographic sub-group, 2002
Prospects
Key target group - do not treat some ailments, but sympathetic towards alternative remedies
Figure 20: Adults who do not use remedies for minor ailments, by gender and age, 2002
Greatest potential
Forecast
A market with potential
Female and middle-aged bias
Figure 21: The CMG, by gender and age, 2002
Future demographics broadly favourable
Figure 22: Forecast of the CMG, by gender and age, 2002
Women to increase importance further
Older target group requires attention to product mix
Appendix: Research Methodology
Index of reports
AbstractThis report examines the complementary medicines market in Spain. As with the other countries in this series, detailed market size data for this niche sector are extremely hard to come by. Consequently, this report examines the overall market environment and consumer attitudes towards using alternative treatments. Readers will be able to gauge how attitudes coincide with and/or differ from the other countries examined in this series of reports and assess the likely consumer base and potential take up of complementary products.
Get Full Details About This Report >>
|
